Get startedLog in
    Picture of Hercules Capital logo

    HTGC — Hercules Capital News Story

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsConservativeMid CapNeutral
    All News

    Brief: Madrigal Pharmaceuticals Announces $300+ Million In Financing Events To Advance Resmetirom Program

    Picture of Hercules Capital logoHercules Capital
    21/12/2022 21:19
    Dec 21 (Reuters) - Hercules Capital Inc  HTGC.N :
    * MADRIGAL PHARMACEUTICALS ANNOUNCES $300+ MILLION IN
FINANCING
EVENTS TO ADVANCE RESMETIROM PROGRAM
    * MADRIGAL PHARMACEUTICALS INC -  INTENDS TO SUBMIT A NEW
DRUG
APPLICATION FOR RESMETIROM IN FIRST HALF OF 2023
    * MADRIGAL PHARMACEUTICALS INC - CO HAS RAISED $259 MILLION
IN
EQUITY SECURITIES SALES AND $50 MILLION IN ADDITIONAL DEBT
FINANCING CAPACITY

Source text for Eikon:  ID:nGNX5lvsmn 
Further company coverage:  HTGC.N 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Hercules Capital

    See all news